These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27217053)

  • 1. The safety of Sino-implant (II) for women with medical conditions or other characteristics: a systematic review.
    Phillips SJ; Steyn PS; Curtis KM
    Contraception; 2016 Sep; 94(3):216-25. PubMed ID: 27217053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety of subcutaneously administered depot medroxyprogesterone acetate (104mg/0.65mL): A systematic review.
    Dragoman MV; Gaffield ME
    Contraception; 2016 Sep; 94(3):202-15. PubMed ID: 26874275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness, safety and acceptability of Sino-implant (II) during the first year of use: results from Kenya and Pakistan.
    Lendvay A; Otieno-Masaba R; Azmat SK; Wheeless A; Hameed W; Shaikh BT; Kuria S; Steiner MJ; Chen M; Feldblum PJ
    Contraception; 2014 Mar; 89(3):197-203. PubMed ID: 24439674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls.
    Bahamondes L; Brache V; Meirik O; Ali M; Habib N; Landoulsi S;
    Hum Reprod; 2015 Nov; 30(11):2527-38. PubMed ID: 26409014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sino-implant (II)--a levonorgestrel-releasing two-rod implant: systematic review of the randomized controlled trials.
    Steiner MJ; Lopez LM; Grimes DA; Cheng L; Shelton J; Trussell J; Farley TM; Dorflinger L
    Contraception; 2010 Mar; 81(3):197-201. PubMed ID: 20159174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levonorgestrel-releasing intrauterine system for endometrial hyperplasia.
    Mittermeier T; Farrant C; Wise MR
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD012658. PubMed ID: 32909630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of levonorgestrel-releasing subdermal contraceptive implants on bone density and bone metabolism.
    Di X; Li Y; Zhang C; Jiang J; Gu S
    Contraception; 1999 Sep; 60(3):161-6. PubMed ID: 10640160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of Sino-implant (II) in routine service delivery in Madagascar.
    Feldblum PJ; Hanitriniaina O; Lendvay A; Hopkins K; Wheeless A; Chen M; Steiner MJ
    Contraception; 2013 Jul; 88(1):103-8. PubMed ID: 23582237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter randomized clinical trial of etonogestrel and levonorgestrel contraceptive implants with nonrandomized copper intrauterine device controls: effect on weight variations up to 3 years after placement.
    Bahamondes L; Brache V; Ali M; Habib N;
    Contraception; 2018 Sep; 98(3):181-187. PubMed ID: 29777663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant.
    Ali M; Akin A; Bahamondes L; Brache V; Habib N; Landoulsi S; Hubacher D;
    Hum Reprod; 2016 Nov; 31(11):2491-2498. PubMed ID: 27671673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review of efficacy with extending contraceptive implant duration.
    Thaxton L; Lavelanet A
    Int J Gynaecol Obstet; 2019 Jan; 144(1):2-8. PubMed ID: 30343503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
    Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
    Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of age on tolerability, safety and effectiveness of subdermal contraceptive implants.
    López Del Cerro E; Serrano Diana C; Castillo Cañadas AM; González Mirasol E; García Santos F; Gómez García MT; González de Merlo G
    J Obstet Gynaecol; 2018 Oct; 38(7):979-984. PubMed ID: 29553853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal contraceptives for contraception in overweight or obese women.
    Lopez LM; Bernholc A; Chen M; Grey TW; Otterness C; Westhoff C; Edelman A; Helmerhorst FM
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD008452. PubMed ID: 27537097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient satisfaction with a levonorgestrel-releasing contraceptive implant. Reasons for and patterns of removal.
    Haugen MM; Evans CB; Kim MH
    J Reprod Med; 1996 Nov; 41(11):849-54. PubMed ID: 8951137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weight change at 12 months in users of three progestin-only contraceptive methods.
    Vickery Z; Madden T; Zhao Q; Secura GM; Allsworth JE; Peipert JF
    Contraception; 2013 Oct; 88(4):503-8. PubMed ID: 23582238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and experiences of American women electing for early removal of contraceptive implants.
    Frank ML; Ditmore JR; Ilegbodu AE; Bateman L; Poindexter AN
    Contraception; 1995 Sep; 52(3):159-65. PubMed ID: 7587187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contraception with two levonorgestrel rod implants. A 5-year study in the United States and Dominican Republic.
    Sivin I; Alvarez F; Mishell DR; Darney P; Wan L; Brache V; Lacarra M; Klaisle C; Stern J
    Contraception; 1998 Nov; 58(5):275-82. PubMed ID: 9883382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants.
    Sivin I
    Drug Saf; 2003; 26(5):303-35. PubMed ID: 12650633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levonorgestrel subdermal implants. Contraception on trial.
    Frank ML; DiMaria C
    Drug Saf; 1997 Dec; 17(6):360-8. PubMed ID: 9429835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.